Previous 10 | Next 10 |
INVO Bioscience to Exhibit at the 2022 Pacific Coast Reproductive Society (PCRS) Annual Meeting PR Newswire SARASOTA, Fla. , March 24, 2022 /PRNewswire/ -- INVO Bioscience, Inc. (NASDAQ: INVO), developers of the INVOcell ® , an advanced f...
INVO Bioscience to Participate in Roundtable Discussion at the 2022 Virtual Growth Conference Presented by Maxim Group LLC and Hosted by M-Vest PR Newswire SARASOTA, Fla. , March 22, 2022 /PRNewswire/ -- INVO Bioscience, Inc. (NASDAQ: INVO), a commercial-...
New Birmingham INVO Center Offers Families an Affordable Advanced Fertility Treatment Solution to Help Combat Rising Costs PR Newswire SARASOTA, Fla. , March 10, 2022 /PRNewswire/ -- INVO Bioscience, Inc. (NASDAQ: INVO), developers of the INVOcell®, ...
INVO to Launch Additional INVO Center in Tampa, Florida Tampa INVO Center to focus on advanced fertility care utilizing INVOcell® PR Newswire SARASOTA, Fla. and TAMPA, Fla. , Feb. 16, 2022 /PRNewswire/ -- INVO Bioscience, Inc. (NASDAQ: ...
SAN FRANCISCO, CA / ACCESSWIRE / February 9, 2022 / Today, the global fertility market is a multi-billion industry, yet remains severely underserved, with estimates suggesting more than 90% of couples in need of infertility treatment going without care. INVO Bioscience (NASDAQ:INVO), a comme...
INVO Bioscience Expands U.S. Commercialization Efforts Focused on addressing underserved patients within the fertility marketplace PR Newswire SARASOTA, Fla. , Feb. 3, 2022 /PRNewswire/ -- INVO Bioscience, Inc. (NASDAQ: INVO) ("Company") ("INVO"), a c...
INVO Bioscience (INVO +2.9%) has entered into an expanded agreement with Ovoclinic, a group of clinics specialized in assisted reproductive treatments with four locations across Spain and collaborating centers around Europe, to accelerate adoption of INVOcell within their markets. The agreeme...
INVO Bioscience Enters into Agreement with Ovoclinic in Spain to Expand INVOcell Commercialization Agreement follows initial utilization of INVOcell by Ovoclinic phyisicians in early 2021, resulting in successful patient experiences and outcomes Ovoclinic will expand use of ...
INVO Bioscience to Participate in the Lytham Partners Winter 2021 Investor Conference PR Newswire SARASOTA, Fla. , Dec. 10, 2021 /PRNewswire/ -- INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo...
INVO Bioscience (NASDAQ:INVO) has received approval by Medical Devices Control Division for FDA Thailand to import and commercialize INVOcell in Thailand. Shares up 9.7% premarket at $3.40. In April 2021, INVO Bio inked exclusive distribution agreement with IVF Envimed Company Ltd. ...
News, Short Squeeze, Breakout and More Instantly...
SARASOTA, Fla., May 15, 2024 (GLOBE NEWSWIRE) -- INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO" or the "Company"), a healthcare services fertility company focused on expanding access to advanced treatment worldwide through the establishment and acquisition of fertility clinics, and with the intrava...
A look at the top 10 most actives in the United States SiNtx Technologies Inc. (SINT) rose 73.2% to $0.0646 on volume of 191,555,690 shares AGBA Group Holding Limited (AGBA) rose 245.0% to $1.38 on volume of 41,065,125 shares TIAN RUIXIANG Holdings Ltd (TIRX) rose 135.2% to $1.14 on volum...
2024-04-18 06:37:00 ET Here’s the Top 3 Reasons to Trade Penny Stocks in 2024 Penny stocks represent a unique investment opportunity for those looking to diversify their portfolios with high-growth potential securities. Characterized by their low price per share, typically under ...